# Title
**Uncertainty-Aware Multi-Fidelity Learning for Accelerated Binding Affinity Prediction**

# Motivation
Binding affinity prediction is critical for drug discovery but faces a fundamental trade-off: high-fidelity methods (e.g., molecular dynamics simulations) are accurate but computationally expensive, while low-fidelity methods (e.g., docking scores) are fast but unreliable. Current deep learning approaches typically rely on single-fidelity data and fail to quantify prediction uncertainty, leading to overconfident predictions that can mislead experimental validation efforts. This results in wasted resources on false positives and missed opportunities on false negatives.

# Main Idea
We propose a Bayesian multi-fidelity neural network framework that jointly learns from diverse data sources with varying accuracy-cost trade-offs. The model employs:

1. **Hierarchical architecture**: Lower layers learn from abundant low-fidelity data (docking scores, fast ML predictions), while upper layers refine predictions using sparse high-fidelity data (experimental binding assays, MD simulations).

2. **Uncertainty quantification**: Variational inference to provide calibrated confidence intervals, enabling risk-aware compound prioritization.

3. **Active learning strategy**: Uncertainty estimates guide selective high-fidelity data acquisition for maximum information gain.

**Expected outcomes**: 10-100x reduction in computational cost while maintaining prediction accuracy comparable to high-fidelity methods. The uncertainty-aware predictions enable intelligent experimental design, reducing false discovery rates by 30-50%. This framework generalizes to other drug discovery tasks requiring multi-scale modeling.